Chief Executive Officer of Pharmaceuticals and Medical devices Bureau of India (PMBI) Ravi Dadhich launched Sitagliptin, a new variant of medicines for diabetes, recently, at affordable prices for all under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana. PMBI included new variants of medicines Sitagliptin and its combination in its all Jan Aushdhi Kendras.
The Maximum Retail Price (MRP) for a pack of 10 is as follows:
(1) Sitagliptin Phosphate Tablet IP 50mg – Rs 60/-
(2) Sitagliptin Phosphate Tablet IP 100mg – Rs 100/-
(3) Sitagliptin + Metformin Hydrochloride Tablets 50mg/500mg – Rs 65/-
(4) Sitagliptin + Metformin Hydrochloride Tablets 50mg/1000mg – Rs 70/-
Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type-II diabetes mellitus. All these variants are available at 60-to-70 per cent lesser prices than branded variants as those are available in price band of Rs 162/- to Rs 258/- at other medical stores.